NDC 51808-127

P32 Sodium Phosphate

P32 Sodium Phosphate

P32 Sodium Phosphate is a Interstitial; Intra-articular; Intraperitoneal; Intrapleural Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Phosphorus P-32.

• Product ID: 51808-127_5ed86373-1e27-42fc-a3b3-b198944f0dff
• NDC: 51808-127
• Product Type: Human Prescription Drug
• Proprietary Name: P32 Sodium Phosphate
• Generic Name: P32 Sodium Phosphate
• Dosage Form: Injection, Suspension
• Route of Administration: INTERSTITIAL; INTRA-ARTICULAR; INTRAPERITONEAL; INTRAPLEURAL
• Marketing Start Date: 2012-06-19
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: AnazaoHealth Corporation
• Substance Name: PHOSPHORUS P-32
• Active Ingredient Strength: 5 mCi/mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 51808-127-01

3 mL in 1 VIAL (51808-127-01)

• Marketing Start Date: 2012-06-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51808-127-01 [51808012701]

P32 Sodium Phosphate INJECTION, SUSPENSION

• Marketing Category: Unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2012-06-19
• Inactivation Date: 2019-11-27

Drug Details

Active Ingredients

Ingredient	Strength
PHOSPHORUS P-32	5 mCi/mL

OpenFDA Data

• SPL SET ID: 4996cd1e-4338-43d7-b7aa-418909ab8c16
• Manufacturer:
  • AnazaoHealth Corporation
• UNII:
  • 690284A407

NDC Crossover Matching brand name "P32 Sodium Phosphate" or generic name "P32 Sodium Phosphate"

NDC	Brand Name	Generic Name
51808-127	P32 Sodium Phosphate	P32 Sodium Phosphate
51808-128	P32 Sodium Phosphate	P32 Sodium Phosphate